Menu Back toHow are Medical and Health Economics Data Generated and Disseminated to Various Customer Segments?
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA 2021 Global Annual Meeting
How are Medical and Health Economics Data Generated and Disseminated to Various Customer Segments?
J. Lynn Bass, PharmD, RPh
- Senior Director, Medical Sciences
- Medexus Pharma, United States
This session will educate professionals in the pharmaceutical, biotech, and device industries and government employees on how medical and health economics data is generated and disseminated to different customer segments in support of both approved and investigational agents. Participants will benefit from an improved understanding of how the regulatory environment is modifying the requirements for pharmaceutical companies to disseminate this data to both the prescribing and decision maker communities.
Learning Objective : Describe health economic and outcomes research and potential consumers of this research; Examine how health economic and outcomes research data is communicated and the expansion of customer segments in this field; Discuss a case study on the benefits and challenges of communicating health economics and outcomes research to a variety of customer segments.
A Discussion: The Communication of Clinical and Health Economic Data to Different Customer Segments - A Global Industry Perspective
Cameron Tew, MBA
- Senior Vice President, Research Services/Business Operations
- Best Practices LLC, United States
A Discussion: The Communication of Clinical and Health Economic Data to Different Customer Segments - An Individual Company Perspective
Donna Booth, PharmD
- Director, Field Medical HTA and Policy, US Medical Affairs
- GlaxoSmithKline, United States